News » Archives » September 2015

September 30, 2015

HCRI researchers win CTSI awards

Holly Weiss-Bilka, a postdoctoral associate in the Department of Biological Sciences, was awarded ‘best poster presentation’ in the postdoctoral division at the 2015 Indiana Clinical and Translational Sciences Institute (CTSI) annual meeting. As part of the award, Weiss-Bilka will receive $1,000 in research supply funds from the Indiana CTSI.

Read full article

September 15, 2015

Introducing Mary Galvin, dean of the College of Science

Mary Galvin, dean of the College of Science

Watch video Video

Mary Galvin, the William K. Warren Foundation Dean of the College of Science, sat down for a brief question-and-answer session about her experience, her passion for scientific research and her new role at the University of Notre Dame.

When asked what drew her to Notre Dame, Galvin is quick to answer: alignment with the University’s mission, and the chance to work with students again.

Read full article

September 15, 2015

Sharon Stack publishes book on HPV-associated oropharyngeal cancer

HPV

Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide. Although the overall incidence of HNSCC has decreased over the years due to public health efforts to promote smoking cessation, the incidence of oropharyngeal (tonsillar area) squamous cell carcinoma (OPSCC), which is associated with human papillomavirus (HPV), has increased over 200% from 1984-2004.

Read full article

September 15, 2015

CTSI Funding Opportunity for Early Stage Commercialization in Diagnostics and Therapeutics Development

SUBMISSION DEADLINETHURSDAY, OCTOBER 01, 2015 (5:00 PM).

A common critical gap in commercialization of technologies originating from the academic labs is the funding necessary to develop a robust commercialization relevant data package to reduce the risk of investment in early stage technologies. The Indiana CTSI

Read full article

September 11, 2015

New awards stimulate cutting-edge biomedical and environmental research at Notre Dame

AD&T

For a third consecutive year, the University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced grant awards for a range of research projects that have the potential to solve significant problems in human and environmental health. The awards foster interdisciplinary research and promote new commercialization activity. Technologies developed through previous grants have been licensed by start-up companies, such as Contect and Enlightened Diagnostics, and spurred collaboration with external partners, including the Indiana University School of Medicine-South Bend, Saint Mary’s College, and Central Michigan University. This year’s projects show similar promise, and for the first time one was selected for joint funding by both AD&T and Notre Dame’s Harper Cancer Research Institute (HCRI).

Read full article

September 09, 2015

Lab Feature: Dr. Sharon Stack

With ovarian cancer ranking fifth in cancer deaths among women, there is an urgent need to increase research to improve early

sharon1_research_day_15

detection, develop new treatments and therapies, and methods for more effective imaging.  Currently, there is no reliable test to detect ovarian cancer in its earliest stages, so the majority of women with the disease are diagnosed after the tumor has already spread. Diagnosis in late stages of the disease dramatically reduces the effectiveness of current treatments and long-term survival. Dr. Sharon Stack, Director of the Harper Cancer Research Institute, and her lab are working to change these outcomes. Using primary and established human ovarian tumor cells and a variety of pre-clinical model systems, the Stack laboratory is investigating the role of changes in the expression and function of various enzymes and adhesion molecules in ovarian cancer metastasis.  More recent studies have begun to evaluate the role of the “host” tissues to ovarian cancer metastatic success.  For example, as the average age at which ovarian cancer is diagnosed is 63, research is addressing the hypothesis that ageing alters the ‘receptivity’ of tissues in the abdominal cavity to metastatic implantation by tumor cells. Additional studies evaluate the role that obesity plays in metastasis of ovarian cancer. Early results suggest that tumor cells adhere more aggressively to peritoneal tissues of mice fed on a high fat diet relative to control mice.…

Read full article

September 09, 2015

New Funding Opportunity to Support Pre-clinical Assays

Drug Development Services through the Molecular Therapeutics Program

SUBMISSION DEADLINE: October 15, 2015

The Molecular Therapeutics Program, a part of the Indiana Clinical and Translational Sciences Institute, has established a service agreement with Covance, Inc. to support early-stage drug discovery within CTSI

Read full article

September 03, 2015

Lieberman Awarded USAID Grant Seeded by CTSI Core Pilot Program

Paper test cards distinguish authentic and falsified oxycodone tablets

Professor Marya Lieberman has been awarded a grant from the US Agency for International Development (USAID) to monitor the quality of pharmaceuticals across western Kenya through the use of innovative diagnostic test cards developed in her laboratory. These inexpensive, point-of-need devices have been shown to detect falsified antibiotics, TB medications, and anti-malarial drugs. 

Read full article

September 03, 2015

Join Notre Dame Research at the Core Facility Fair

On Wednesday, September 16th, 2015, Notre Dame Research will host its annual Core Facility Fair from 10:00 a.m. to 2:00 p.m. in the Jordan Hall of Science Galleria.

Read full article